Business Description
Founded in 1923 and based in Denmark, Novo Nordisk is a global pharmaceutical company best known for its treatments targeting diabetes and obesity, as well as a range of rare conditions affecting blood, hormones, and growth. The company develops and sells medicines, smart insulin delivery devices, and digital dosing tools, serving patients across North America, Europe, Asia, Latin America, and beyond.
